Skip navigation

Patient-Centric Strategies for Early Access and Product Launch

June 19-20, 2018
  • Boston, MA

New technological advances and therapeutic developments are expanding the possibilities for rare disease therapies at a rapid pace! CBI’s Rare Disease Innovation Summit brings together diverse stakeholders to discuss the most pressing challenges to successful market access and commercialization. The summit provides a unique opportunity to share best practices and lessons learned in this complex but exciting environment. Benefit from hearing about the experiences of industry, advocates and patients on successful collaboration on accelerated approvals and increased patient access.

Hear Cutting-Edge Insights and
Discuss Key Challenges:

  • Create a Foundation for Success and Explore Innovative
    approaches to Orphan Drug Commercialization
  • Activate Specific Leverage Points in Commercializing
    Rare Disease Portfolios
  • Understand the Impact of Patient Engagement on
    Product Valuation
  • Delve into Next-Generation Models for Collaboration
    with Patients and Advocates
  • Examine Evolving Reimbursement Trends for
    Rare Disease Products
  • Learn About Innovative Opportunities to Demonstrate Value
    for Rare Disease Products to Support Market Access
Rare Disease by the Numbers:

Rare Disease Innovation Summit

Patient-Centric Strategies for Early Access and Product Launch

New technological advances and therapeutic developments are expanding the possibilities for rare disease therapies at a rapid pace! CBI’s Rare Disease Innovation Summit brings together diverse stakeholders to discuss the most pressing challenges to successful market access and commercialization. The summit provides a unique opportunity to share best practices and lessons learned in this complex but exciting environment. Benefit from hearing about the experiences of industry, advocates and patients on successful collaboration on accelerated approvals and increased patient access.

Hear Cutting-Edge Insights and
Discuss Key Challenges:

  • Create a Foundation for Success and Explore Innovative
    approaches to Orphan Drug Commercialization
  • Activate Specific Leverage Points in Commercializing
    Rare Disease Portfolios
  • Understand the Impact of Patient Engagement on
    Product Valuation
  • Delve into Next-Generation Models for Collaboration
    with Patients and Advocates
  • Examine Evolving Reimbursement Trends for
    Rare Disease Products
  • Learn About Innovative Opportunities to Demonstrate Value
    for Rare Disease Products to Support Market Access
Rare Disease by the Numbers: